Agile Therapeutics (Nasdaq:AGRX), a women’s healthcare company, announced that on January 9, 2019 it received final meeting minutes from its December 11, 2018 meeting with the U.S. Food and Drug Administration’s Division of Bone, Reproductive, and Urologic Products. As quoted in the press release: In its meeting with DBRUP, the Company discussed the specific design … Continued
The post Agile Therapeutics Provides Regulatory Update and Reiterates Cash Guidance appeared first on Investing News Network.